Templeton Mary B Esq - Net Worth and Insider Trading
Templeton Mary B Esq Net Worth
The estimated net worth of Templeton Mary B Esq is at least $1 dollars as of 2024-11-13. Templeton Mary B Esq is the SVP, Gen Counsel & Corp Sec of Windtree Therapeutics Inc and owns about 2 shares of Windtree Therapeutics Inc (WINT) stock worth over $1. Details can be seen in Templeton Mary B Esq's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Templeton Mary B Esq has not made any transactions after 2020-05-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Templeton Mary B Esq
Templeton Mary B Esq Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Templeton Mary B Esq owns 1 companies in total, including Windtree Therapeutics Inc (WINT) .
Click here to see the complete history of Templeton Mary B Esq’s form 4 insider trades.
Insider Ownership Summary of Templeton Mary B Esq
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
WINT | Windtree Therapeutics Inc | 2020-05-22 | Senior VP & General Counsel |
Templeton Mary B Esq Latest Holdings Summary
Templeton Mary B Esq currently owns a total of 1 stock. Templeton Mary B Esq owns 2 shares of Windtree Therapeutics Inc (WINT) as of May 22, 2020, with a value of $1.
Latest Holdings of Templeton Mary B Esq
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
WINT | Windtree Therapeutics Inc | 2020-05-22 | 2 | 0.56 | 1 |
Holding Weightings of Templeton Mary B Esq
Templeton Mary B Esq Form 4 Trading Tracker
According to the SEC Form 4 filings, Templeton Mary B Esq has made a total of 1 transactions in Windtree Therapeutics Inc (WINT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Windtree Therapeutics Inc is the acquisition of 1 shares on May 22, 2020, which cost Templeton Mary B Esq around $7,997.
Insider Trading History of Templeton Mary B Esq
- 1
Templeton Mary B Esq Trading Performance
GuruFocus tracks the stock performance after each of Templeton Mary B Esq's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Templeton Mary B Esq is 5.77%. GuruFocus also compares Templeton Mary B Esq's trading performance to market benchmark return within the same time period. The performance of stocks bought by Templeton Mary B Esq within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Templeton Mary B Esq's insider trading performs compared to the benchmark.
Performance of Templeton Mary B Esq
Templeton Mary B Esq Ownership Network
Ownership Network List of Templeton Mary B Esq
Ownership Network Relation of Templeton Mary B Esq
Templeton Mary B Esq Owned Company Details
What does Windtree Therapeutics Inc do?
Who are the key executives at Windtree Therapeutics Inc?
Templeton Mary B Esq is the Senior VP & General Counsel of Windtree Therapeutics Inc. Other key executives at Windtree Therapeutics Inc include director & Chief Executive Officer Craig Fraser , VP & Controller & & CAO Jamie Mcandrew , and SVP & CFO John P. Hamill .
Windtree Therapeutics Inc (WINT) Insider Trades Summary
Over the past 18 months, Templeton Mary B Esq made no insider transaction in Windtree Therapeutics Inc (WINT). Other recent insider transactions involving Windtree Therapeutics Inc (WINT) include a net purchase of 10,431 shares made by Craig Fraser ,
In summary, during the past 3 months, insiders sold 0 shares of Windtree Therapeutics Inc (WINT) in total and bought 5,431 shares, with a net purchase of 5,431 shares. During the past 18 months, 0 shares of Windtree Therapeutics Inc (WINT) were sold and 5,709 shares were bought by its insiders, resulting in a net purchase of 5,709 shares.
Windtree Therapeutics Inc (WINT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Windtree Therapeutics Inc Insider Transactions
Templeton Mary B Esq Mailing Address
Above is the net worth, insider trading, and ownership report for Templeton Mary B Esq. You might contact Templeton Mary B Esq via mailing address: 2600 Kelly Rd, Warrington Pa 18976.